Re-transplants compared to primary kidney transplants recipients: A mate kidney paired analysis of the OPTN/UNOS database

Ali K. Khalil, James E. Slaven, Muhammad A. Mujtaba, Muhammad Yaqub, Dennis P. Mishler, Tim Taber, Asif Sharfuddin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Outcomes of kidney re-transplant recipients (RTR) were compared to primary recipients (FTR) from paired donor kidneys. Organ Procurement and Transplantation Network (OPTN) database was used to identify deceased donors (n = 6266) who donated one kidney to an RTR and the mate kidney to an FTR between January 2000 to December 2010. As compared to FTR, RTR were younger (45 vs. 52 yr, p <0.001) and had higher proportion of plasma reactive antibody >80 (25% vs 7%, p <0.001). There were higher 0 mismatches in RTR (19% vs. 16%, p <0.001). There were more pre-emptive transplants in RTR (24% vs. 21%, p = 0.002). Delayed graft function (28% vs. 25%, p = 0.007) was higher in RTR. Patient survival was similar in FTR and RTR groups at one, three, and five yr (95.7%, 90.2%, and 82.5% vs. 95.2%, 89.8% and 82.7%). Allograft survival rates were higher in FTR group compared to RTR group at one, three, and five yr (91.1%, 82.4%, and 70.9% vs. 87.8%, 77.4%, and 66.1% p <0.001). Death-censored allograft survival rates were higher in FTR group at one, three, and five yr (91.3%, 82.7% and 71.4% vs. 88%, 77.7% and 66.5% p <0.001). In today's era of modern immunosuppression, graft survival in RTR has improved but remains inferior to FTR when controlling for donor factors.

Original languageEnglish (US)
JournalClinical Transplantation
DOIs
StateAccepted/In press - 2016

Fingerprint

Tissue and Organ Procurement
Organ Transplantation
Databases
Transplants
Kidney
Tissue Donors
Allografts
Survival Rate
Delayed Graft Function
Transplant Recipients
Graft Survival
Immunosuppression
Survival

Keywords

  • UNOS
  • Kidney
  • Outcomes
  • Recipients
  • Retransplant
  • Transplant

ASJC Scopus subject areas

  • Transplantation

Cite this

Re-transplants compared to primary kidney transplants recipients : A mate kidney paired analysis of the OPTN/UNOS database. / Khalil, Ali K.; Slaven, James E.; Mujtaba, Muhammad A.; Yaqub, Muhammad; Mishler, Dennis P.; Taber, Tim; Sharfuddin, Asif.

In: Clinical Transplantation, 2016.

Research output: Contribution to journalArticle

@article{a2ac65ea2b9b49ca8f5216db0e26560e,
title = "Re-transplants compared to primary kidney transplants recipients: A mate kidney paired analysis of the OPTN/UNOS database",
abstract = "Outcomes of kidney re-transplant recipients (RTR) were compared to primary recipients (FTR) from paired donor kidneys. Organ Procurement and Transplantation Network (OPTN) database was used to identify deceased donors (n = 6266) who donated one kidney to an RTR and the mate kidney to an FTR between January 2000 to December 2010. As compared to FTR, RTR were younger (45 vs. 52 yr, p <0.001) and had higher proportion of plasma reactive antibody >80 (25{\%} vs 7{\%}, p <0.001). There were higher 0 mismatches in RTR (19{\%} vs. 16{\%}, p <0.001). There were more pre-emptive transplants in RTR (24{\%} vs. 21{\%}, p = 0.002). Delayed graft function (28{\%} vs. 25{\%}, p = 0.007) was higher in RTR. Patient survival was similar in FTR and RTR groups at one, three, and five yr (95.7{\%}, 90.2{\%}, and 82.5{\%} vs. 95.2{\%}, 89.8{\%} and 82.7{\%}). Allograft survival rates were higher in FTR group compared to RTR group at one, three, and five yr (91.1{\%}, 82.4{\%}, and 70.9{\%} vs. 87.8{\%}, 77.4{\%}, and 66.1{\%} p <0.001). Death-censored allograft survival rates were higher in FTR group at one, three, and five yr (91.3{\%}, 82.7{\%} and 71.4{\%} vs. 88{\%}, 77.7{\%} and 66.5{\%} p <0.001). In today's era of modern immunosuppression, graft survival in RTR has improved but remains inferior to FTR when controlling for donor factors.",
keywords = "UNOS, Kidney, Outcomes, Recipients, Retransplant, Transplant",
author = "Khalil, {Ali K.} and Slaven, {James E.} and Mujtaba, {Muhammad A.} and Muhammad Yaqub and Mishler, {Dennis P.} and Tim Taber and Asif Sharfuddin",
year = "2016",
doi = "10.1111/ctr.12722",
language = "English (US)",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Re-transplants compared to primary kidney transplants recipients

T2 - A mate kidney paired analysis of the OPTN/UNOS database

AU - Khalil, Ali K.

AU - Slaven, James E.

AU - Mujtaba, Muhammad A.

AU - Yaqub, Muhammad

AU - Mishler, Dennis P.

AU - Taber, Tim

AU - Sharfuddin, Asif

PY - 2016

Y1 - 2016

N2 - Outcomes of kidney re-transplant recipients (RTR) were compared to primary recipients (FTR) from paired donor kidneys. Organ Procurement and Transplantation Network (OPTN) database was used to identify deceased donors (n = 6266) who donated one kidney to an RTR and the mate kidney to an FTR between January 2000 to December 2010. As compared to FTR, RTR were younger (45 vs. 52 yr, p <0.001) and had higher proportion of plasma reactive antibody >80 (25% vs 7%, p <0.001). There were higher 0 mismatches in RTR (19% vs. 16%, p <0.001). There were more pre-emptive transplants in RTR (24% vs. 21%, p = 0.002). Delayed graft function (28% vs. 25%, p = 0.007) was higher in RTR. Patient survival was similar in FTR and RTR groups at one, three, and five yr (95.7%, 90.2%, and 82.5% vs. 95.2%, 89.8% and 82.7%). Allograft survival rates were higher in FTR group compared to RTR group at one, three, and five yr (91.1%, 82.4%, and 70.9% vs. 87.8%, 77.4%, and 66.1% p <0.001). Death-censored allograft survival rates were higher in FTR group at one, three, and five yr (91.3%, 82.7% and 71.4% vs. 88%, 77.7% and 66.5% p <0.001). In today's era of modern immunosuppression, graft survival in RTR has improved but remains inferior to FTR when controlling for donor factors.

AB - Outcomes of kidney re-transplant recipients (RTR) were compared to primary recipients (FTR) from paired donor kidneys. Organ Procurement and Transplantation Network (OPTN) database was used to identify deceased donors (n = 6266) who donated one kidney to an RTR and the mate kidney to an FTR between January 2000 to December 2010. As compared to FTR, RTR were younger (45 vs. 52 yr, p <0.001) and had higher proportion of plasma reactive antibody >80 (25% vs 7%, p <0.001). There were higher 0 mismatches in RTR (19% vs. 16%, p <0.001). There were more pre-emptive transplants in RTR (24% vs. 21%, p = 0.002). Delayed graft function (28% vs. 25%, p = 0.007) was higher in RTR. Patient survival was similar in FTR and RTR groups at one, three, and five yr (95.7%, 90.2%, and 82.5% vs. 95.2%, 89.8% and 82.7%). Allograft survival rates were higher in FTR group compared to RTR group at one, three, and five yr (91.1%, 82.4%, and 70.9% vs. 87.8%, 77.4%, and 66.1% p <0.001). Death-censored allograft survival rates were higher in FTR group at one, three, and five yr (91.3%, 82.7% and 71.4% vs. 88%, 77.7% and 66.5% p <0.001). In today's era of modern immunosuppression, graft survival in RTR has improved but remains inferior to FTR when controlling for donor factors.

KW - UNOS

KW - Kidney

KW - Outcomes

KW - Recipients

KW - Retransplant

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=84963593393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963593393&partnerID=8YFLogxK

U2 - 10.1111/ctr.12722

DO - 10.1111/ctr.12722

M3 - Article

C2 - 26915071

AN - SCOPUS:84963593393

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

ER -